The UK must increase investment in innovative medicines and vaccines if it is to deliver on the NHS 10-Year Plan and drive ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

A Senate committee this week will almost surely push forward the FDA and NIH nominees. Neither one has the public interest at ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

Following a year of strategic expansion, European medicine-related companies are advancing their operations in Vietnam.

Imagine being one of the millions of Americans in need of a hip or knee replacement due to osteoarthritis. Severe pain, reduced physical activity, an inability to perform many routine ...

The high street chemist was caught selling Wegovy – a prescription-only drug – to a 16-year-old undercover reporter ...

A recent CNN report cast a spotlight on Akeso, a Chinese biotech company whose immunotherapy ivonescimab drug, now in ...

Could taking tiny fractions of the normal prescribed dose of a medication offer a brilliant way to benefit from the drug, ...

The National Institutes of Health (NIH) serves as an important source of funding for clinical trials in children, especially ...

More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...